Gilbert R. Gonzales

Part of Xanodyne Pharmaceuticals, Inc., Drug Enhancement Co of America LLC is a privately held product development organization dedicated to the creation of innovative healthcare technologies. The company is based in Union, KY. DECA's technologies are formulated by board certified pharmacologists and undergo rigorous safety, tolerability and efficacy testing and are then confirmed through IRB reviewed, human clinical trials. DECA has developed numerous platform technologies that have become cornerstone products for some highly successful companies including Richwood Pharmaceuticals, Integrity Pharmaceuticals, Xanodyne Pharmaceuticals, and the Union Springs family of companies (acquired by Enzymotec Ltd NASDAQ ENZY 2017). Once completed, the technology is professionally positioned to maximize valuation by strategic introduction into their commercialization network. The company was founded by Gilbert R. Gonzales. Drug Enhancement Co of America was acquired by Xanodyne Pharmacal, Inc. on January 07, 2002.

Clear Vascular, Inc. develops radionuclide products for multiple clinical applications. The firm has developed an injectable, targeted radiopharmaceutical agent, Tin-Annexin, for imaging and therapy of inflammatory tissues, initially targeting vulnerable and unstable plaque. It is a private radiopharmaceutical company developing a unique radionuclide for multiple clinical applications including diagnosis and therapy. The company was founded by Gilbert R. Gonzales in 2005 and is headquartered in Austin, TX.

Part of Navidea Biopharmaceuticals, Inc., RHEUMCO LLC is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Dover, DE. The company was founded by Gilbert R. Gonzales.

Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY.

Prism Pharmaceuticals, Inc. manufactures cardiovascular injectables and pharmaceutical products. The firm engages in developing and commercializing branded cardiovascular injectable products which include NEXTERONE. The company was founded by Gilbert R. Gonzales and Cameron Durrant in 2003 and is headquartered in King of Prussia, PA.

Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY.

Serene Medical, Inc. develops pharmaceutical and drug products. It targets overactive motor nerves. The company was founded by Gilbert R. Gonzales and Bankim Mehta in 2010 and is headquartered in Pleasanton, CA.

Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas.